I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Differentiation status of primary chronic myeloid leukemia ..:
Pietarinen, Paavo O
;
Eide, Christopher A
;
Ayuda-Duran, Pilar
...
10.18632/oncotarget.15146. , 2020
Link:
http://hdl.handle.net/10138/312086
RT Journal T1
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
UL https://suche.suub.uni-bremen.de/peid=base-ftunivhelsihelda:oai:helda.helsinki.fi:10138_312086&Exemplar=1&LAN=DE A1 Pietarinen, Paavo O A1 Eide, Christopher A A1 Ayuda-Duran, Pilar A1 Potdar, Swapnil A1 Kuusanmaki, Heikki A1 Andersson, Emma I A1 Mpindi, John P A1 Pemovska, Tea A1 Kontro, Mika A1 Heckman, Caroline A A1 Kallioniemi, Olli A1 Wennerberg, Krister A1 Hjorth-Hansen, Henrik A1 Druker, Brian J A1 Enserink, Jorrit M A1 Tyner, Jeffrey W A1 Mustjoki, Satu A1 Porkka, Kimmo PB Impact Journals LLC YR 2020 K1 chronic myeloid leukemia K1 high-throughput drug screening K1 ex vivo K1 tyrosine kinase inhibitors K1 CD34 K1 CHRONIC MYELOGENOUS LEUKEMIA K1 DRUG-SENSITIVITY K1 STEM-CELLS K1 RESISTANCE K1 IMATINIB K1 MECHANISMS K1 DASATINIB K1 CRKL K1 Cancers JF 10.18632/oncotarget.15146 LK http://hdl.handle.net/10138/312086 DO http://hdl.handle.net/10138/312086 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)